Literature DB >> 9709981

Variations in the vitamin D-binding protein (Gc locus) are associated with oral glucose tolerance in nondiabetic Pima Indians.

L J Baier1, A M Dobberfuhl, R E Pratley, R L Hanson, C Bogardus.   

Abstract

Electrophoretic variants of the vitamin D-binding protein (DBP) have been associated with type 2 diabetes as well as with metabolic characteristics that predispose to type 2 diabetes in several populations. The Gc gene that encodes DBP maps to chromosome 4q12, a region that has recently been found to be potentially linked to plasma glucose and insulin concentrations in Pima Indians. Therefore, the gene that encodes DBP was analyzed as a candidate gene for our linkage findings in the Pima Indians. Sequence analysis of the coding exons identified two previously described missense polymorphisms at codons 416 and 420, which are the genetic basis for the three common electrophoretic variants of DBP (Gc1f, Gc1s, and Gc2). These variants in DBP were associated with differences in oral glucose tolerance in nondiabetic Pima Indians.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9709981     DOI: 10.1210/jcem.83.8.5043

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  24 in total

1.  Insulin resistance indices are inversely associated with vitamin D binding protein concentrations.

Authors:  Ambika P Ashraf; Carrie Huisingh; Jessica A Alvarez; Xudong Wang; Barbara A Gower
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

2.  Race, vitamin D-binding protein gene polymorphisms, 25-hydroxyvitamin D, and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Jared P Reis; Erin D Michos; Elizabeth Selvin; James S Pankow; Pamela L Lutsey
Journal:  Am J Clin Nutr       Date:  2015-04-29       Impact factor: 7.045

3.  Alterations in circulating levels of vitamin D binding protein, total and bioavailability of vitamin D in diabetic retinopathy patients.

Authors:  Zhila Maghbooli; Sepideh Ebrahimi Meimand; Ali-Asghar Malek Hosseini; Arash Shirvani
Journal:  BMC Endocr Disord       Date:  2022-07-01       Impact factor: 3.263

4.  The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome.

Authors:  H Selimoglu; C Duran; S Kiyici; C Ersoy; M Guclu; G Ozkaya; E Tuncel; E Erturk; S Imamoglu
Journal:  J Endocrinol Invest       Date:  2009-10-09       Impact factor: 4.256

5.  Vitamins D, C, and E in the prevention of type 2 diabetes mellitus: modulation of inflammation and oxidative stress.

Authors:  Bibiana Garcia-Bailo; Ahmed El-Sohemy; Pierre S Haddad; Paul Arora; Firas Benzaied; Mohamed Karmali; Alaa Badawi
Journal:  Biologics       Date:  2011-01-19

6.  Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention.

Authors:  Alaa Badawi; Amira Klip; Pierre Haddad; David Ec Cole; Bibiana Garcia Bailo; Ahmed El-Sohemy; Mohamed Karmali
Journal:  Diabetes Metab Syndr Obes       Date:  2010-05-26       Impact factor: 3.168

Review 7.  Focus on vitamin D, inflammation and type 2 diabetes.

Authors:  Carlos Eduardo Andrade Chagas; Maria Carolina Borges; Lígia Araújo Martini; Marcelo Macedo Rogero
Journal:  Nutrients       Date:  2012-01-20       Impact factor: 5.717

8.  Relationship between insulin resistance and plasma vitamin D in adults.

Authors:  Alaa Badawi; Suzan Sayegh; Eman Sadoun; Mohamed Al-Thani; Paul Arora; Pierre S Haddad
Journal:  Diabetes Metab Syndr Obes       Date:  2014-07-07       Impact factor: 3.168

Review 9.  Role of vitamin D in insulin resistance.

Authors:  Chih-Chien Sung; Min-Tser Liao; Kuo-Cheng Lu; Chia-Chao Wu
Journal:  J Biomed Biotechnol       Date:  2012-09-03

Review 10.  Common variants of the vitamin D binding protein gene and adverse health outcomes.

Authors:  Suneil Malik; Lei Fu; David James Juras; Mohamed Karmali; Betty Y L Wong; Agnes Gozdzik; David E C Cole
Journal:  Crit Rev Clin Lab Sci       Date:  2013-02-22       Impact factor: 6.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.